Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments

Valerio De Stefano, Tommaso Za, Elena Rossi, Alessandro M. Vannucchi, Marco Ruggeri, Elena Elli, Caterina Micò, Alessia Tieghi, Rossella R. Cacciola, Cristina Santoro, Giancarla Gerli, Nicola Vianelli, Paola Guglielmelli, Lisa Pieri, Francesca Scognamiglio, Francesco Rodeghiero, Enrico M. Pogliani, Guido Finazzi, Luigi Gugliotta, Roberto MarchioliGiuseppe Leone, Tiziano Barbui

Research output: Contribution to journalArticle

187 Citations (Scopus)

Abstract

Background: Prior thrombosis is a well-established risk factor for re-thrombosis in polycythemia vera and essential thrombocythemia but scarce data are available on the rate of re-thrombosis and the optimal strategy for prevention of recurrence. Design and Methods: We retrospectively estimated the rate of recurrence in a multicenter cohort of 494 patients (polycythemia vera/essential thrombocythemia 235/259) with previous arterial (67.6%) or venous thrombosis (31%) or both (1.4%). First thrombosis was cerebrovascular disease in 191 cases, acute coronary syndrome in 106, peripheral arterial thrombosis in 44, and venous thromboembolism in 160. Microcirculatory events were not computed. Results: Thrombosis recurred in 166 patients (33.6%), with an incidence of 7.6% patient-years. Sex, diagnosis (polycythemia vera or essential thrombocythemia), and presence of vascular risk factors did not predict recurrence, whereas age >60 years did (multivariable hazard ratio [HR], 1.67; 95% confidence interval [CI] 1.19-2.32). Increased leukocyte count at the time of the first thrombosis was a risk factor for recurrence in patients

Original languageEnglish
Pages (from-to)372-380
Number of pages9
JournalHaematologica
Volume93
Issue number3
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Essential Thrombocythemia
Polycythemia Vera
Thrombosis
Incidence
Recurrence
Therapeutics
Cerebrovascular Disorders
Venous Thromboembolism
Acute Coronary Syndrome
Leukocyte Count
Venous Thrombosis
Confidence Intervals

Keywords

  • Antiplatelet treatment
  • Cytoreductive treatment
  • Essential thrombocythemia
  • Oral anticoagulant treatment
  • Polycythemia vera
  • Recurrent thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia : Incidence, risk factors, and effect of treatments. / De Stefano, Valerio; Za, Tommaso; Rossi, Elena; Vannucchi, Alessandro M.; Ruggeri, Marco; Elli, Elena; Micò, Caterina; Tieghi, Alessia; Cacciola, Rossella R.; Santoro, Cristina; Gerli, Giancarla; Vianelli, Nicola; Guglielmelli, Paola; Pieri, Lisa; Scognamiglio, Francesca; Rodeghiero, Francesco; Pogliani, Enrico M.; Finazzi, Guido; Gugliotta, Luigi; Marchioli, Roberto; Leone, Giuseppe; Barbui, Tiziano.

In: Haematologica, Vol. 93, No. 3, 03.2008, p. 372-380.

Research output: Contribution to journalArticle

De Stefano, V, Za, T, Rossi, E, Vannucchi, AM, Ruggeri, M, Elli, E, Micò, C, Tieghi, A, Cacciola, RR, Santoro, C, Gerli, G, Vianelli, N, Guglielmelli, P, Pieri, L, Scognamiglio, F, Rodeghiero, F, Pogliani, EM, Finazzi, G, Gugliotta, L, Marchioli, R, Leone, G & Barbui, T 2008, 'Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments', Haematologica, vol. 93, no. 3, pp. 372-380. https://doi.org/10.3324/haematol.12053
De Stefano, Valerio ; Za, Tommaso ; Rossi, Elena ; Vannucchi, Alessandro M. ; Ruggeri, Marco ; Elli, Elena ; Micò, Caterina ; Tieghi, Alessia ; Cacciola, Rossella R. ; Santoro, Cristina ; Gerli, Giancarla ; Vianelli, Nicola ; Guglielmelli, Paola ; Pieri, Lisa ; Scognamiglio, Francesca ; Rodeghiero, Francesco ; Pogliani, Enrico M. ; Finazzi, Guido ; Gugliotta, Luigi ; Marchioli, Roberto ; Leone, Giuseppe ; Barbui, Tiziano. / Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia : Incidence, risk factors, and effect of treatments. In: Haematologica. 2008 ; Vol. 93, No. 3. pp. 372-380.
@article{71502e2acfdd408bae2d1e3deab73310,
title = "Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments",
abstract = "Background: Prior thrombosis is a well-established risk factor for re-thrombosis in polycythemia vera and essential thrombocythemia but scarce data are available on the rate of re-thrombosis and the optimal strategy for prevention of recurrence. Design and Methods: We retrospectively estimated the rate of recurrence in a multicenter cohort of 494 patients (polycythemia vera/essential thrombocythemia 235/259) with previous arterial (67.6{\%}) or venous thrombosis (31{\%}) or both (1.4{\%}). First thrombosis was cerebrovascular disease in 191 cases, acute coronary syndrome in 106, peripheral arterial thrombosis in 44, and venous thromboembolism in 160. Microcirculatory events were not computed. Results: Thrombosis recurred in 166 patients (33.6{\%}), with an incidence of 7.6{\%} patient-years. Sex, diagnosis (polycythemia vera or essential thrombocythemia), and presence of vascular risk factors did not predict recurrence, whereas age >60 years did (multivariable hazard ratio [HR], 1.67; 95{\%} confidence interval [CI] 1.19-2.32). Increased leukocyte count at the time of the first thrombosis was a risk factor for recurrence in patients",
keywords = "Antiplatelet treatment, Cytoreductive treatment, Essential thrombocythemia, Oral anticoagulant treatment, Polycythemia vera, Recurrent thrombosis",
author = "{De Stefano}, Valerio and Tommaso Za and Elena Rossi and Vannucchi, {Alessandro M.} and Marco Ruggeri and Elena Elli and Caterina Mic{\`o} and Alessia Tieghi and Cacciola, {Rossella R.} and Cristina Santoro and Giancarla Gerli and Nicola Vianelli and Paola Guglielmelli and Lisa Pieri and Francesca Scognamiglio and Francesco Rodeghiero and Pogliani, {Enrico M.} and Guido Finazzi and Luigi Gugliotta and Roberto Marchioli and Giuseppe Leone and Tiziano Barbui",
year = "2008",
month = "3",
doi = "10.3324/haematol.12053",
language = "English",
volume = "93",
pages = "372--380",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia

T2 - Incidence, risk factors, and effect of treatments

AU - De Stefano, Valerio

AU - Za, Tommaso

AU - Rossi, Elena

AU - Vannucchi, Alessandro M.

AU - Ruggeri, Marco

AU - Elli, Elena

AU - Micò, Caterina

AU - Tieghi, Alessia

AU - Cacciola, Rossella R.

AU - Santoro, Cristina

AU - Gerli, Giancarla

AU - Vianelli, Nicola

AU - Guglielmelli, Paola

AU - Pieri, Lisa

AU - Scognamiglio, Francesca

AU - Rodeghiero, Francesco

AU - Pogliani, Enrico M.

AU - Finazzi, Guido

AU - Gugliotta, Luigi

AU - Marchioli, Roberto

AU - Leone, Giuseppe

AU - Barbui, Tiziano

PY - 2008/3

Y1 - 2008/3

N2 - Background: Prior thrombosis is a well-established risk factor for re-thrombosis in polycythemia vera and essential thrombocythemia but scarce data are available on the rate of re-thrombosis and the optimal strategy for prevention of recurrence. Design and Methods: We retrospectively estimated the rate of recurrence in a multicenter cohort of 494 patients (polycythemia vera/essential thrombocythemia 235/259) with previous arterial (67.6%) or venous thrombosis (31%) or both (1.4%). First thrombosis was cerebrovascular disease in 191 cases, acute coronary syndrome in 106, peripheral arterial thrombosis in 44, and venous thromboembolism in 160. Microcirculatory events were not computed. Results: Thrombosis recurred in 166 patients (33.6%), with an incidence of 7.6% patient-years. Sex, diagnosis (polycythemia vera or essential thrombocythemia), and presence of vascular risk factors did not predict recurrence, whereas age >60 years did (multivariable hazard ratio [HR], 1.67; 95% confidence interval [CI] 1.19-2.32). Increased leukocyte count at the time of the first thrombosis was a risk factor for recurrence in patients

AB - Background: Prior thrombosis is a well-established risk factor for re-thrombosis in polycythemia vera and essential thrombocythemia but scarce data are available on the rate of re-thrombosis and the optimal strategy for prevention of recurrence. Design and Methods: We retrospectively estimated the rate of recurrence in a multicenter cohort of 494 patients (polycythemia vera/essential thrombocythemia 235/259) with previous arterial (67.6%) or venous thrombosis (31%) or both (1.4%). First thrombosis was cerebrovascular disease in 191 cases, acute coronary syndrome in 106, peripheral arterial thrombosis in 44, and venous thromboembolism in 160. Microcirculatory events were not computed. Results: Thrombosis recurred in 166 patients (33.6%), with an incidence of 7.6% patient-years. Sex, diagnosis (polycythemia vera or essential thrombocythemia), and presence of vascular risk factors did not predict recurrence, whereas age >60 years did (multivariable hazard ratio [HR], 1.67; 95% confidence interval [CI] 1.19-2.32). Increased leukocyte count at the time of the first thrombosis was a risk factor for recurrence in patients

KW - Antiplatelet treatment

KW - Cytoreductive treatment

KW - Essential thrombocythemia

KW - Oral anticoagulant treatment

KW - Polycythemia vera

KW - Recurrent thrombosis

UR - http://www.scopus.com/inward/record.url?scp=40849085151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849085151&partnerID=8YFLogxK

U2 - 10.3324/haematol.12053

DO - 10.3324/haematol.12053

M3 - Article

C2 - 18268279

AN - SCOPUS:40849085151

VL - 93

SP - 372

EP - 380

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -